Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study.

ABSTRACT:

Background

The holistic evolution of patient engagement in medicines development requires a more detailed understanding of the needs of all involved stakeholders, and one that better accounts for the specific needs of some potentially vulnerable patient populations and key stages in medicines development.

Objective

The purpose of this convergent mixed-methods study was to better understand the needs of different stakeholders concerning patient engagement at three key stages in medicines development: research priority setting, clinical trial design and early dialogues with Health Technology Assessment bodies and regulators.

Design

This study brought together findings from three sources: i) an online questionnaire, ii) face-to-face consultations with two potentially vul

SUBMITTER: Faulkner SD 

PROVIDER: S-EPMC8077078 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature